New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
The proposal seeks to move any future LDT authority away from the FDA
Federal prosecutors continue to target situations where third-party recruiters influence test ordering
Know Labs and ProPhase Laboratories discussed plans that in part involve digital currencies
CMS tweaked its CE, documentation, and on-site visit requirements for directors
With new modifications to HIPAA potentially on the horizon, we hear from experts on HHS’ proposal
The Syn-One assay can diagnose multiple conditions without needing a lumbar puncture
The technology developed by Roche in recent years seems a good fit for Labcorp’s testing services
Third-party verification of lab personnel experience is now a CLIA requirement
Bill that ended government shutdown includes provision to hold off PAMA cuts
How clinical laboratories should prepare for the next wave of oversight in the new year
Australian firm has grown its overseas operations dramatically in the past decade, except in America